Key result
Precision medicine, based on large-scale cohort and omic studies, is increasingly applied to the prevention, diagnosis, and treatment of cardiovascular diseases.
This review summarizes the application of precision medicine, including large-scale cohorts and multiomics, to the prevention, diagnosis, and treatment of cardiovascular diseases.
May guide precision CVD strategies via multiomics; leaves open prospective validation before clinical use.
Since President Obama announced the Precision Medicine Initiative in the United States, more and more attention has been paid to precision medicine. However, clinicians have already used it to treat conditions such as cancer. Many cardiovascular diseases have a familial presentation, and genetic variants are associated with the prevention, diagnosis, and treatment of cardiovascular diseases, which are the basis for providing precise care to patients with cardiovascular diseases. Large-scale cohorts and multiomics are critical components of precision medicine. Here we summarize the application of precision medicine to cardiovascular diseases based on cohort and omic studies, and hope to elicit discussion about future health care.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2017) conducted a review in Cardiovascular diseases. Precision medicine was evaluated. Precision medicine, based on large-scale cohort and omic studies, is increasingly applied to the prevention, diagnosis, and treatment of cardiovascular diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: